drugset / Trial / NCT04747977
To Assess the Efficacy and Safety of OTX-DED for the Short-term Treatment of Signs and Symptoms of Dry Eye Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the efficacy and safety of OTX-DED for the short-term treatment of signs and symptoms of dry eye disease.
Timeline
- Start
- 2021-02-12
- Primary completion
- 2021-08-11
- Completion
- 2021-09-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexamethasone | Small molecule | 0.2 mg | Other |
| Comparator | Dexamethasone | Small molecule | 0.3 mg | Other |